Four-week nebulized beclomethasone dipropionate in stable COPD patients with exertional dyspnoea

Monaldi Archives for Chest Disease

Volumn 54, Issue 3, 1999, Pages 224-227

  Melani, A S ^a,b   Di Gregorio, A ^a  

^a Respiratory Rehabilitation Care Unit   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Aerosol therapy; Beclomethasone dipropionate; Chronic obstructive pulmonary disease; Dyspnoea; Nebulizer

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO;

AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; NEBULIZER; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL;

EID: 0032767722     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Melani AS. - Pharmacological treatment of exertional dyspnoea in stable COPD patients. Monaldi Arch Chest Dis 1997; 52: 354-362.
2. Barnes NC. - Inhaled steroids in COPD. Lancet 1998; 351: 766-767.
3. Callahan CM, Dittus RS, Katz BP. - Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 1991; 114: 216-223.
4. Weir DC, Burge SP. - Effects of high dose inhaled beclomethasone dipropionate, 750 μg and 1500 μg twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax 1993; 48: 309-316.
5. Mc Evoy CE, Niewoehner DE. - Adverse effects of corticosteroid therapy for COPD. Chest 1997; 111: 732-743.
6. Shim CS, Williams MH Jr. - Aerosol.beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. Am J Med 1985; 78: 655-658.
7. Robertson AS, Grove WI, Wieland GA, Burge PS. - A double-blind comparison of oral prednisolone 40 mg/day with inhaled beclomethasone dipropionate 1,500 μg/day in patients with adult onset chronic obstructive airways disease. Eur J Respir Dis 1986; 69: Suppl. 146: 565-569.
8. Wardman AG, Simpson FG, Knox AJ, Page RL, Cooke NJ. - The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways disease. Br J Dis Chest 1988; 82: 168-171.
9. Engel T, Heinig JH, Madsen O, Hansen M, Weeke ER. - A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur Respir J 1989; 2: 935-939.
10. Weir DC, Gove RJ, Robertson AS, Burge SP. - Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990; 45: 112-117.
11. Weir DC, Robertson AS, Gove RI, Burge PS. - Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow limitation. Thorax 1990; 45: 118-121.
12. Weir DC, Gove RI, Robertson AS, Burge SP. - Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse. Eur Respir J 1991; 4: 1185-1190.
13. Auffarth B, Postma DS, de Monchy JG, van der Mark TW, Boorsma M, Koeter GH. - Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991; 46: 372-377.
14. Watson A, Lim TK, Joyce H, Pride NB. - Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction. Chest 1992; 101: 350-355.
15. Thompson AB, Mueller MB, Heires AJ, et al. - Aerosolized beclomethasone in chronic bronchitis: improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis 1992; 146: 389-395.
16. Weiner P, Weiner M, Azgad Y, Zamir D. - Inhaled budesonide therapy for patients with stable COPD. Chest 1995; 108: 1568-1571.
17. Renkema TEJ, Schouten JP, Koeter GH, Postma DS. - Effects of long-term treatment with corticosteroids in COPD. Chest 1996; 109: 1156-1162.
18. Llewellyn-Jones CG, Harris TAJ, Stockley RA. - The effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153: 616-621.
19. Keatings VM, Jatakanon A, Worsdell YM, Barnes P. - Effects of inhaled and oral glucocorticoids in inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155: 542-548.
20. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J, on behalf of the International COPD Study Group. - Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998; 351: 773-780.
21. McGavin CR, Gupta SP, Mc Hardy GJR. - Twelve minute walking test for assessing disability in chronic bronchitis. BMJ 1976; 1: 822-823.
22. McGavin CR, Artvinli M, Naoe H, Mc Hardy GJR. - Dyspnoea, disability and distance walked: comparison of exercise performance in respiratory disease. BMJ 1978; 2: 241-243.
23. Aitken RCB. - Measurement of feelings using visual analogue scales. Proc R Soc Med 1969; 62: 989-993.
24. Mahler D, Matthay R, Snyder P, Wells C, Loke J. - Sustained-release theophylline reduces dyspnea in nonreversible obstructive airways disease. Am Rev Respir Dis 1985; 131: 22-25.
25. Guyatt GH, Townsend M, Pugsley SO, et al. - Bronchodilators in chronic airflow limitation. Am Rev Respir Dis 1987; 135: 1069-1074.
26. Webb J, Clark TJ, Chilvers C. - Time course of response to prednisolone in chronic airflow obstruction. Thorax 1981; 36: 18-21.
27. Stark RD. - Dyspnoea: assessment and pharmacological manipulation. Eur Respir J 1988; 1: 280-287.
28. Chanez P, Vignola AM, O'Shaugnessy T, et al. - Corticosteroid therapy in COPD is related to features of asthma. Am J Respir Crit Care Med 1997; 155: 1529-1534.
29. 1 during long-term inhaled corticosteroid treatment. Eur Respir J 1993; 6: 868-876.
30. Anthonisen NR, Wright EC, and the IPPB Trial Group. - Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 814-819.
31. O' Donohue WJ Jr (chairman). - Guidelines for the use of nebulizers in the home and at domiciliary sites. Chest 1996; 109: 814-820.
32. Melani AS. - Home nebulised therapy in the district of Siena. Rassegna Patologia Apparato Respiratorio 1998; 13: 229-233.
33. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. - Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99: 837-841.
34. van der Palen J, Klein JJ, Rovers MM. - Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 1997; 10: 652-657.
35. O' Callaghan C. - Particle size of beclomethasone dipropionate produced by 2 nebulizers and spacers. Thorax 1990; 45: 109-111.